BioAge Labs, Inc. (BIOA)
6.36
-0.25
(-3.78%)
USD |
NASDAQ |
Oct 05, 16:00
6.31
-0.05
(-0.79%)
After-Hours: 07:22
BioAge Labs Gross Profit Margin (Quarterly) : 97.14% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.14% |
| March 31, 2026 | 97.73% |
| December 31, 2025 | 97.76% |
| Date | Value |
|---|---|
| September 30, 2025 | 97.61% |
| June 30, 2025 | 97.60% |
| March 31, 2025 | 97.45% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Neumora Therapeutics, Inc. | -- |
| Alumis, Inc. | 47.41% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.55% |
| Return on Assets | -27.50% |
| Return on Invested Capital | -29.04% |
| Profit Margin (Quarterly) | -1.06K% |
| Operating Margin (Quarterly) | -1.20K% |
| Return on Net Operating Assets | -2.11K% |